Access to a blood plasma treatment for seriously ill coronavirus patients has been made easier by the U.S. Food and Drug Administration. What to know:
The FDA decision is a"big step" forward, Dr.
Arturo Casadevall, chief of molecular microbiology and immunology at Johns Hopkins Bloomberg School of Public Health, told"It has a high likelihood of working, but we won't know whether it works until it's done" and enough patients have been treated, he said."We do know, based on history, it has a good chance," said Casadevall, who has pushed for the plasma treatment.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
FDA Approves Plasma Treatment for Coronavirus on Conditional BasisThe blood plasma of patients who have recovered from Covid-19 will be allowed for conditional use in treating the disease even though the effectiveness is unproven.
続きを読む »
FDA will allow doctors to treat critically ill coronavirus patients with blood from survivorsUnder new emergency protocols approved Tuesday, FDA will allow doctors across the US to begin using plasma donated by coronavirus survivors to treat patients who are critically ill with the virus.
続きを読む »
FDA says it is expediting the use of a blood plasma treatment as New York begins to roll out new clinical trialsThe US Food and Drug Administration on Tuesday said it is expediting the use of a blood plasma treatment for patients seriously ill with the coronavirus, making it easier for doctors to try another tool to attack the illness.
続きを読む »
China's Hubei eases coronavirus curbs; new imported cases declineChina's Hubei, the epicentre of the country's coronavirus outbreak, st...
続きを読む »
Jordan eases nationwide curfew and allows shops to openJordanian Prime Minister Omar Razzaz said on Tuesday the government would allow ...
続きを読む »
Fed's stimulus eases global market fears, gets cash flowingInvestors across a broad range of asset markets breathed a sigh of relief Tuesda...
続きを読む »